drugset / Trial / NCT04710381
IMUNOR® Preparation in the Prevention of COVID-19
NaSingle-groupOpen-labelPrevention
Summary
The aim of the study is to achieve prevention of COVID-19 disease in healthcare professionals with the administration of the IMUNOR® preparation, and decreasing the symptoms should the disease appear.
Timeline
- Start
- 2021-02-01
- Primary completion
- 2021-06-02
- Completion
- 2021-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMUNOR | Unknown | 1 unknown | Oral |